LNWWM
INBX icon

Laird Norton Wetherby Wealth Management’s Inhibrx INBX Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.37M Hold
40,656
– – 0.06% 315
2025
Q2 		$580K Buy
+40,656
New +$526K 0.03% 515
2024
Q4 		$472K Sell
30,656
-2,026
-6% -$30.9K 0.02% 548
2024
Q3 		$512K Hold
32,682
– – 0.02% 553
2024
Q2 		$463K Buy
+32,682
New +$511K 0.02% 560

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's INBX Position: Q3 2025 in Review

Laird Norton Wetherby Wealth Management held its Inhibrx (INBX) position steady in Q3 2025 at 40,656 shares worth $1.37M. The position accounts for 0.06% of the portfolio, ranked #315.

Laird Norton Wetherby Wealth Management first reported a position in INBX in Q2 2024 and has held it in 5 quarters since. 102 funds tracked by Wall St. Rank hold INBX as of Q3 2025.

  • Laird Norton Wetherby Wealth Management held 40,656 shares of Inhibrx worth $1.37M as of Q3 2025.
  • Laird Norton Wetherby Wealth Management left its Inhibrx share count unchanged in Q3 2025.
  • Inhibrx made up 0.06% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #315 holding.
  • Laird Norton Wetherby Wealth Management first reported a position in Inhibrx in Q2 2024 and has held it in 5 quarters since.
  • 102 funds tracked by Wall St. Rank held Inhibrx as of Q3 2025.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.